Systemic Scleroderma: A Deep Dive into the Complexity of a Multi-System Autoimmune Connective Tissue Disease
Main Article Content
Abstract
Systemic scleroderma, a complex and rare autoimmune connective tissue disease, represents a significant clinical and scientific challenge due to its clinical heterogeneity, multisystem involvement, and potential for severe disability and complications. This article examines in depth the epidemiological, clinical, diagnostic and therapeutic aspects associated with this complex condition. Through a comprehensive review, it highlights the importance of a multidisciplinary medical approach to properly evaluate and manage the disease, from early detection to the implementation of specific therapeutic strategies targeting affected organs and systems. It also emphasizes the need for continued research to better understand the underlying pathogenic mechanisms and develop more effective therapies, with the goal of improving the outcomes and quality of life of patients affected by this complex autoimmune condition.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. E.C. LeRoy, C. Black, R. Fleischmajer, S. Jablonska, T. Krieg, T.A. Medsger Jr, et al.Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol, 15 (1988), pp. 202-205.
II. L. Chung, J. Lin, D.E. Furst, D. Fiorentino. Systemic and localized scleroderma. Clin Dermatol, 24 (2006), pp. 374-392
http://dx.doi.org/10.1016/j.clindermatol.2006.07.004
III. H. Chifflot, B. Fautzi, C. Sordet, E. Chatelus, J. Sibilia. Incidence and prevalence of systemic sclerosis: A systematic literature review. Semin Arthritis Reum, 37 (2008), pp. 223-235.
IV. M.D. Mayes. Scleroderma epidemiology. Rheum Dis Clin North Am, 29 (2003), pp. 239-254.
T.J. Laing, B.W. Gillespie, M.B. Toth, M.D. Mayes, R.H. Gallavan Jr. Gillespie, M.B. Toth, M.D. Mayes, R.H. Gallavan Jr, C.J. Burns, et al.
V. Racial differences in scleroderma among women in Michigan. Arthritis Rheum, 40 (1997), pp. 734-742 http://dx.doi.org/10.1002/1529-0131(199704)40:4<734::AID-ART20>3.0.CO;2-3
VI. R. Vancheeswaran, C.M. Black, J. David, N. Hasson, J. Harper, D. Atherton, et al.Childhood-onset scleroderma: Is it different from adult-onset disease. Arthritis Rheum, 39 (1996), pp. 1041-1049.
VII. K. Scalapino, T. Arkachaisri, M. Lucas, N. Fertig, D.J. Helfrich, A.V. Londino Jr, et al.Childhood onset systemic sclerosis: Classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol, 33 (2006), pp. 1004-1013.
VIII. K. Aoyama, Y. Nagai, Y. Endo, O. Ishikawa. Juvenile systemic sclerosis: report of three cases and review of Japanese published work. J Dermatol, 34 (2007), pp. 656-658.
IX. G.F. Mora. Systemic sclerosis: Environmental factors. J Rheumatol, 36 (2009), pp. 2383-2396 http://dx.doi.org/10.3899/jrheum.090207
X. E. Fonseca. Cutaneous manifestations of toxic syndrome due to adulterated rapeseed oil. Actas Dermosifiliogr, 100 (2009), pp. 857-860.
XI. L.D. Kaufman, R.J. Seidman, M.E. Phillips, B.L. Gruber. Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: A spectrum of sclerodermatous skin disease. J Am Acad Dermatol, 23 (1990), pp. 1063-1069.
XII. J.D. Reveille. Ethnicity and race and systemic sclerosis: How it affects susceptibility, severity, antibody genetics and clinical manifestations. Curr Rheumatol Rep, 5 (2003), pp. 160-167.
XIII. J.D. Reveille, M. Fischbach, T. McNearney, A.W. Friedman, M.B. Aguilar, J. Lisse, et al.Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic and immunogenetic determinants. Semin Arthritis Rheum, 30 (2001), pp. 332-346 http://dx.doi.org/10.1053/sarh.2001.20268
XIV. N.S. Gendi, K.I. Welsh, W.J. Van Venrooij, R. Vancheeswaran, J. Gilroy, C.M. Black.HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum, 38 (1995), pp. 259-266.
XV. F.C. Arnett.HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol, 12 (1995), pp. 107-128.